Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

96.69 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,487
Open 96.69
Bid (Size) 97.05 (100)
Ask (Size) 97.80 (500)
Prev. Close 96.69
Today's Range 96.69 - 96.69
52wk Range 81.97 - 135.45
Shares Outstanding 1,750,942,289
Dividend Yield 2.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway. ↗
Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock. 
Via The Motley Fool
News headline image
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? ↗
Intuitive Surgical is beating estimates and raising margins while its installed base keeps expanding. Abbott is executing steadily across a diversified portfolio but growing at a more measured pace. 
Via The Motley Fool

Performance

YTD
-22.1%
-22.1%
1 Month
-11.2%
-11.2%
3 Month
+1.4%
+1.4%
6 Month
-6.0%
-6.0%
1 Year
-27.6%
-27.6%

More News

Read More
News headline image
Want a Portfolio That Pays You $1,000 a Month in Passive Income? This Dividend ETF Could Get You There. ↗
Via The Motley Fool
Topics ETFs
Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles ↗
Via Chartmill
News headline image
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors ↗
Via The Motley Fool
News headline image
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth ↗
Via The Motley Fool
Topics Product Recall
News headline image
3 Dividend Stocks to Buy and Hold for 10 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Wall Street Is Becoming Even More Bullish About This Dividend King ↗
Via The Motley Fool
News headline image
JEPI and JEPQ Yield Way More Than SCHD, but SCHD Could Produce More Passive Income Over the Long Term. Here's Why. ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
SCHD's Stunning Reversal: Schwab's Flagship Dividend ETF Is Up 29% and Climbing ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs World Trade
News headline image
If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King ↗
Via The Motley Fool
News headline image
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗
Via MarketBeat
Topics Artificial Intelligence Bonds
News headline image
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Just Starting Out With $5,000? 3 Magnificent ETFs to Buy in 2026. ↗
Via The Motley Fool
Topics ETFs
News headline image
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy. ↗
Via The Motley Fool
News headline image
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock ↗
Via Benzinga
News headline image
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗
Via Benzinga
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Recession-Proofing Your Portfolio Before the Storm Hits ↗
Via The Motley Fool
Topics Economy

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 96.69
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 10/01/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 169.30B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 169B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.